By Ms Nicki Susan Meagher

Book Chapters

Smee RI; Wiliams J; Schneider M; Meagher N, 2010, 'Non-Surgical Management of Meningiomas Involving the Cavernous Sinus: Radiosurgery', in Radiosurgery, Basal Karger, pp. 189 - 201, http://dx.doi.org/10.1159/000288730

Journal articles

O’Mahony DG; Ramus SJ; Southey MC; Meagher NS; Hadjisavvas A; John EM; Hamann U; Imyanitov EN; Andrulis IL; Sharma P; Daly MB; Hake CR; Weitzel JN; Jakubowska A; Godwin AK; Arason A; Bane A; Simard J; Soucy P; Caligo MA; Mai PL; Claes KBM; Teixeira MR; Chung WK; Lazaro C; Hulick PJ; Toland AE; Pedersen IS; Mourits MJE; Neuhausen SL; Vega A; de la Hoya M; Nevanlinna H; Dhawan M; Zampiga V; Danesi R; Varesco L; Gismondi V; Vellone VG; James PA; Janavicius R; Nikitina-Zake L; Nielsen FC; van Overeem Hansen T; Pejovic T; Borg A; Rantala J; Offit K; Montagna M; Nathanson KL; Domchek SM; Osorio A; García MJ; Karlan BY; Lesueur F; De Fazio A; Bowtell D; De Fazio A; McGuffog L; Leslie G; Parsons MT; Dörk T; Speith LM; dos Santos ES; da Costa AABA; Radice P; Peterlongo P; Papi L; Engel C; Hahnen E; Schmutzler RK; Wappenschmidt B; Easton DF; Tischkowitz M; Singer CF; Tan YY; Whittemore AS; Sieh W; Brenton JD; Yannoukakos D; Fostira F; Konstantopoulou I; Soukupova J; Vocka M; Chenevix-Trench G; Pharoah PDP; Antoniou AC; Goldgar DE; Spurdle AB; Michailidou K; dos Santos ES, 2023, 'Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2', British Journal of Cancer, 128, pp. 2283 - 2294, http://dx.doi.org/10.1038/s41416-023-02263-5

Kobel M; Kang E-Y; Weir A; Rambau PF; Lee C-H; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubinski J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramon Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; Garcia MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PDP; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD, 2023, 'p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study', JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 9, pp. 208 - 222, http://dx.doi.org/10.1002/cjp2.311

Kang EY; Weir A; Meagher NS; Farrington K; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Bolithon A; Popovic G; Leung B; Tang K; Lambie N; Millstein J; Alsop J; Anglesio MS; Ataseven B; Barlow E; Beckmann MW; Berger J; Bisinotto C; Bösmüller H; Boros J; Brand AH; Brooks-Wilson A; Brucker SY; Carney ME; Casablanca Y; Cazorla-Jiménez A; Cohen PA; Conrads TP; Cook LS; Coulson P; Courtney-Brooks M; Cramer DW; Crowe P; Cunningham JM; Cybulski C; Darcy KM; El-Bahrawy MA; Elishaev E; Erber R; Farrell R; Fereday S; Fischer A; García MJ; Gayther SA; Gentry-Maharaj A; Gilks CB; Grube M; Harnett PR; Harrington SP; Harter P; Hartmann A; Hecht JL; Heikaus S; Hein A; Heitz F; Hendley J; Hernandez BY; Polo SH; Heublein S; Hirasawa A; Høgdall E; Høgdall CK; Horlings HM; Huntsman DG; Huzarski T; Jewell A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Khabele D; Kommoss FKF; Kruitwagen RFPM; Lambrechts D; Le ND; Lener M; Lester J; Leung Y; Linder A; Loverix L; Lubiński J; Madan R; Maxwell GL; Modugno F; Neuhausen SL; Olawaiye A; Olbrecht S; Orsulic S; Palacios J; Pearce CL; Pike MC; Quinn CM; Mohan GR; Rodríguez-Antona C; Ruebner M; Ryan A; Salfinger SG, 2023, 'CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study', Cancer, 129, pp. 697 - 713, http://dx.doi.org/10.1002/cncr.34582

Weir A; Kang EY; Meagher NS; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Gentry-Maharaj A; Ryan A; Singh N; Widschwendter M; Alsop J; Anglesio MS; Beckmann MW; Berger J; Bisinotto C; Boros J; Brand AH; Brenton JD; Brooks-Wilson A; Carney ME; Cunningham JM; Cushing-Haugen KL; Cybulski C; Elishaev E; Erber R; Fereday S; Fischer A; Paz-Ares L; Gayarre J; Gilks BC; Grube M; Harnett PR; Harris HR; Hartmann A; Hein A; Hendley J; Hernandez BY; Heublein S; Huang Y; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kommoss FKF; Koziak JM; Kraemer B; Le ND; Lesnock J; Lester J; Lubiński J; Menkiszak J; Ney B; Olawaiye A; Orsulic S; Osorio A; Robles-Díaz L; Ruebner M; Shah M; Sharma R; Shvetsov YB; Steed H; Talhouk A; Taylor SE; Traficante N; Vierkant RA; Wang C; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido dos Reis FJ; Cook LS; DeFazio A; Bowtell D; DeFazio A; Traficante N; Fereday S; Brand A; Harnett P; Sharma R; Doherty JA; Fasching PA; García MJ; Goode EL; Goodman MT; Gronwald J; Huntsman DG; Karlan BY; Kommoss S; Modugno F; Schildkraut JM; Sinn HP; Staebler A; Kelemen LE; Ford CE; Menon U; Pharoah PDP; Köbel M, 2023, 'Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study', British Journal of Cancer, 128, pp. 137 - 147, http://dx.doi.org/10.1038/s41416-022-02014-y

Meagher NS; Hamilton P; Milne K; Thornton S; Harris B; Weir A; Alsop J; Bisinoto C; Brenton JD; Brooks-Wilson A; Chiu DS; Cushing-Haugen KL; Fereday S; Garsed DW; Gayther SA; Gentry-Maharaj A; Gilks B; Jimenez-Linan M; Kennedy CJ; Le ND; Piskorz AM; Riggan MJ; Shah M; Singh N; Talhouk A; Widschwendter M; Bowtell DDL; Candido dos Reis FJ; Cook LS; Fortner RT; García MJ; Harris HR; Huntsman DG; Karnezis AN; Köbel M; Menon U; Pharoah PDP; Doherty JA; Anglesio MS; Pike MC; Pearce CL; Friedlander ML; DeFazio A; Nelson BH; Ramus SJ, 2023, 'Profiling the immune landscape in mucinous ovarian carcinoma', Gynecologic Oncology, 168, pp. 23 - 31, http://dx.doi.org/10.1016/j.ygyno.2022.10.022

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt KA; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim BG; Kim JW; Kim JH; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubinski J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park SY; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F, 2022, 'Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes', Clinical Cancer Research, 28, pp. 5383 - 5395, http://dx.doi.org/10.1158/1078-0432.CCR-22-1206

Kang EY; Millstein J; Popovic G; Meagher NS; Bolithon A; Talhouk A; Chiu DS; Anglesio MS; Leung B; Tang K; Lambie N; Pavanello M; Da-anoy A; Lambrechts D; Loverix L; Olbrecht S; Bisinotto C; Garcia-Donas J; Ruiz-Llorente S; Yagüe-Fernandez M; Edwards RP; Elishaev E; Olawaiye A; Taylor S; Ataseven B; du Bois A; Harter P; Lester J; Høgdall CK; Armasu SM; Huang Y; Vierkant RA; Wang C; Winham SJ; Heublein S; Kommoss FKF; Cramer DW; Sasamoto N; van-Wagensveld L; Lycke M; Mateoiu C; Joseph J; Pike MC; Odunsi K; Tseng CC; Pearce CL; Bilic S; Conrads TP; Hartmann A; Hein A; Jones ME; Leung Y; Beckmann MW; Ruebner M; Schoemaker MJ; Terry KL; El-Bahrawy MA; Coulson P; Etter JL; LaVigne-Mager K; Andress J; Grube M; Fischer A; Neudeck N; Robertson G; Farrell R; Barlow E; Quinn C; Hettiaratchi A; Casablanca Y; Erber R; Stewart CJR; Tan A; Yu Y; Boros J; Brand AH; Harnett PR; Kennedy CJ; Nevins N; Morgan T; Fasching PA; Vergote I; Swerdlow AJ; Candido dos Reis FJ; Maxwell GL; Neuhausen SL; Barquin-Garcia A; Modugno F; Moysich KB; Crowe PJ; Hirasawa A; Heitz F; Karlan BY; Goode EL; Sinn P; Horlings HM; Høgdall E; Sundfeldt K; Kommoss S; Staebler A, 2022, 'MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma', Virchows Archiv, 480, pp. 855 - 871, http://dx.doi.org/10.1007/s00428-021-03232-0

Xu X; Wang Y; Bryce NS; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Targeting the actin/tropomyosin cytoskeleton in epithelial ovarian cancer reveals multiple mechanisms of synergy with anti-microtubule agents', British Journal of Cancer, 125, pp. 265 - 276, http://dx.doi.org/10.1038/s41416-021-01420-y

Quinn CM; Porwal M; Meagher NS; Hettiaratchi A; Power C; Jonnaggadala J; McCullough S; Macmillan S; Tang K; Liauw W; Goldstein D; Zeps N; Crowe PJ, 2021, 'Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability', Biomarker Insights, 16, pp. 1 - 10, http://dx.doi.org/10.1177/11772719211005745

Kang EY; Cheasley D; LePage C; Wakefield MJ; da Cunha Torres M; Rowley S; Salazar C; Xing Z; Allan P; Bowtell DDL; Mes-Masson AM; Provencher DM; Rahimi K; Kelemen LE; Fasching PA; Doherty JA; Goodman MT; Goode EL; Deen S; Pharoah PDP; Brenton JD; Sieh W; Mateoiu C; Sundfeldt K; Cook LS; Le ND; Anglesio MS; Gilks CB; Huntsman DG; Kennedy CJ; Traficante N; Chenevix-Trench G; Green A; Webb P; De Fazio A; Gertig D; Traficante N; Fereday S; Moore S; Hung J; Harrap K; Sadkowsky T; Pandeya N; Malt M; Mellon A; Robertson R; Bergh TV; Jones M; Mackenzie P; Maidens J; Nattress K; Chiew YE; Stenlake A; Sullivan H; Alexander B; Ashover P; Brown S; Corrish T; Green L; Jackman L; Ferguson K; Martin K; Martyn A; Ranieri B; White J; Jayde V; Mamers P; Bowes L; Galletta L; Giles D; Hendley J; Alsop K; Schmidt T; Shirley H; Ball C; Young C; Viduka S; Tran H; Bilic S; Glavinas L; Brooks J; Stuart-Harris R; Kirsten F; Rutovitz J; Clingan P; Glasgow A; Proietto A; Braye S; Otton G; Shannon J; Bonaventura T; Stewart J; Begbie S; Friedlander M; Bell D; Baron-Hay S; Ferrier A; Gard G; Nevell D; Pavlakis N, 2021, 'Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses', Modern Pathology, 34, pp. 194 - 206, http://dx.doi.org/10.1038/s41379-020-0618-9

Meagher NS; Wang L; Rambau PF; Intermaggio MP; Huntsman DG; Wilkens LR; El-Bahrawy MA; Ness RB; Odunsi K; Steed H; Herpel E; Anglesio MS; Zhang B; Lambie N; Swerdlow AJ; Lubiński J; Vierkant RA; Goode EL; Menon U; Toloczko-Grabarek A; Oszurek O; Bilic S; Talhouk A; García-Closas M; Wang Q; Tan A; Farrell R; Kennedy CJ; Jimenez-Linan M; Sundfeldt K; Etter JL; Menkiszak J; Goodman MT; Klonowski P; Leung Y; Winham SJ; Moysich KB; Behrens S; Kluz T; Edwards RP; Gronwald J; Modugno F; Hernandez BY; Chow C; Kelemen LE; Keeney GL; Carney ME; Natanzon Y; Robertson G; Sharma R; Gayther SA; Alsop J; Luk H; Karpinskyj C; Campbell I; Sinn P; Gentry-Maharaj A; Coulson P; Chang-Claude J; Shah M; Widschwendter M; Tang K; Schoemaker MJ; Koziak JM; Cook LS; Brenton JD; Daley F; Kristjansdottir B; Mateoiu C; Larson MC; Harnett PR; Jung A; deFazio A; Gorringe KL; Pharoah PDP; Minoo P; Stewart C; Bathe OF; Gui X; Cohen P; Ramus SJ; Köbel M, 2019, 'A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases', Modern Pathology, 32, pp. 1834 - 1846, http://dx.doi.org/10.1038/s41379-019-0302-0

Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML, 2018, 'Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials', Gynecologic Oncology, 150, pp. 527 - 533, http://dx.doi.org/10.1016/j.ygyno.2018.07.013

Na R; Laaksonen MA; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM, 2016, 'Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia', British Journal of Haematology, 174, pp. 550 - 562, http://dx.doi.org/10.1111/bjh.14083

Na R; Laaksonen MA; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM, 2016, 'High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study Presented orally at the 42nd Annual Scientific Meeting of the Clinical Oncology Society of Australia in Hobart, Australia on November 17, 2015.', Journal of the American Academy of Dermatology, 74, pp. 1144 - 1152.e6, http://dx.doi.org/10.1016/j.jaad.2015.12.044

Na R; Laaksonen MA; Grulich AE; Webster AC; Meagher NS; Mccaughan GW; Keogh AM; Vajdic CM, 2015, 'Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006', Clinical Transplantation, 29, pp. 978 - 990, http://dx.doi.org/10.1111/ctr.12617

Vajdic CM; Marashi Pour S; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L, 2015, 'Corrigendum to "The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study" [Drug Alcohol Depend. 152C (2015) 264-271] DOI: 10.1016/j.drugalcdep.2015.03.026', Drug and Alcohol Dependence, 154, pp. 304, http://dx.doi.org/10.1016/j.drugalcdep.2015.06.024

Vajdic CM; Pour SM; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L, 2015, 'The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study', Drug and Alcohol Dependence, 152, pp. 264 - 271, http://dx.doi.org/10.1016/j.drugalcdep.2015.03.026

Swart A; Meagher NS; Van Leeuwen MT; Zhao K; Grulich A; Mao L; Randall DA; Degenhardt L; Burns L; O'Connell D; Amin J; Vajdic CM, 2015, 'Examining the quality of name code record linkage: What is the impact on death and cancer risk estimates? A validation study', Australian and New Zealand Journal of Public Health, 39, pp. 141 - 147, http://dx.doi.org/10.1111/1753-6405.12287

Meagher NS; Dean S; Koegelenberg A; Goode S; Caruso L; Pillai U; Marsh DJ; Brown S; Yip S; Walczak A; Kench JG; Horvath L; Nielsen S; Scott R; Hawkins NJ, 2014, 'INTEGRATING UNIVERSAL CONSENT FOR BIOBANKING AND HEALTH DATA COLLECTION WITHIN CLINICAL PATHWAYS IN NSW - THE BSN CONSENT PROJECT', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 22 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koegelenberg AM; Dean S; Meagher NS; Caruso L; Goode S; Pillai U; Marsh DJ; Brown S; Walczak A; Yip S; Kench JG; Horvath L; Nielsen S; Hawkins NJ; Scott R, 2014, 'CLOSING THE GAP BETWEEN RESEARCH, BIOBANKS AND CLINICAL PRACTICE: A 12 MONTH EXPLORATORY STUDY INTO DEVELOPING A STANDARD PRE-OPERATIVE MODEL FOR OBTAINING BIOBANK CONSENT', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 35 - 35, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM, 2014, 'Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006', International Journal of Cancer, 135, pp. 2146 - 2156, http://dx.doi.org/10.1002/ijc.28849

Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA, 2014, 'An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data', Cancer Epidemiology, 38, pp. 460 - 464, http://dx.doi.org/10.1016/j.canep.2014.05.004

Vajdic CM; Chong AH; Kelly PJ; Meagher NS; Van Leeuwen MT; Grulich AE; Webster AC, 2014, 'Survival after cutaneous melanoma in kidney transplant recipients: A population-based matched cohort study', American Journal of Transplantation, 14, pp. 1368 - 1375, http://dx.doi.org/10.1111/ajt.12716

Na R; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM, 2013, 'Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients', Am J Transplant, 13, pp. 174 - 183, http://dx.doi.org/10.1111/j.1600-6143.2012.04302.x

Na R; Grulich AE; Meagher N; Mccaughan GW; Keogh AM; Vajdic CM, 2013, 'De novo cancer-related death in Australian liver and cardiothoracic transplant recipients', American Journal of Transplantation, 13, pp. 1296 - 1304, http://dx.doi.org/10.1111/ajt.12192

Van Leeuwen MT; Turner J; Falster M; Meagher N; Joske D; Grulich AE; Giles GG; Vajdic CM, 2013, 'Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure', International Journal of Cancer, http://dx.doi.org/10.1002/ijc.28081

Vajdic CM; Meagher N; Hicks S; Faedo M; Ward RL; Pearson S, 2012, 'Governance approval for multisite, non-interventional research: What can Harmonisation of Multi-Centre Ethical Review learn from the New South Wales experience?', Internal Medicine Journal, 42, pp. 127 - 131, http://dx.doi.org/10.1111/j.1445-5994.2011.02431.x

Smee RI; Williams JR; D K; Meagher N; Cohn R, 2012, 'Medulloblastoma: Progress over time', Journal of Medical Imaging and Radiation Oncology, 56, pp. 227 - 234

Swart AM; Burns LA; Mao L; Grulich AE; Amin J; O Connell DL; Meagher N; Randall D; Degenhardt LJ; Vajdic CM, 2012, 'The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study', BMJ Open, 2, pp. e001755 - e001755, http://dx.doi.org/10.1136/bmjopen-2012-001755

Smee RI; Broadley K; Williams JR; Meagher N; Bridger P, 2011, 'Retained Role of Surgery for Olfactory Neuroblastoma', Head and Neck, 33, pp. 1486 - 1492, http://dx.doi.org/10.1002/hed.21644

Smee RI; Meagher N; Williams JR; Broadley K, 2010, 'The Role of Radiotherapy for Early Glottic Carcinoma', Head and Neck: Journal for the Sciences and Specialties of the Head and Neck, 32, pp. 850 - 859

Smee RI; Meagher N; Broadley K; Ho T; Williams JR; Bridger GP, 2009, 'Recurrent Nasopharyngeal Carcinoma - Current Management Approaches',

Conference Papers

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy', in Cancer Research, American Association for Cancer Research (AACR), pp. 1045 - 1045, http://dx.doi.org/10.1158/1538-7445.am2021-1045

Jonnagaddala J; Croucher JL; Jue TR; Meagher NS; Caruso L; Ward R; Hawkins NJ, 2016, 'Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research', in Nursing Informatics 2016, pp. 387 - 387

Na R; Grulich A; Meagher N; McCaughan G; Keogh A; Laaksonen M; Vajdic C, 2014, 'Risk of Early and Late Non-Hodgkin Lymphoma (NHL) in Australian Liver and Cardiothoracic Transplant Recipients.', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, CA, San Francisco, pp. 67 - 67, presented at World Transplant Congress, CA, San Francisco, 26 July 2014 - 31 July 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338033300213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Na R; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Laaksonen M; Vajdic CM, 2014, 'RISK OF EARLY AND LATE NON-HODGKIN LYMPHOMA (NHL) IN AUSTRALIAN LIVER AND CARDIOTHORACIC TRANSPLANT RECIPIENTS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, pp. A9 - A9, presented at 32nd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, ANU Campus, Canberra, 10 June 2014 - 13 June 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342376300022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

Schaffer AL; Pearson S-A; Dobbins T; Er C; Meagher NS; Barrett J; Ward RL; Vajdic CM, 2013, 'HEALTH SERVICE USE, TREATMENT PATTERNS, AND SURVIVAL FOR CANCER OF UNKNOWN PRIMARY: A DATA LINKAGE STUDY', Vol. 9, pp. 98 - 98, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Meagher NS; Hamilton PT; Anglesio MS; Harris HR; Konecny GE; Schildkraut JM; Talhouk A; Friedlander ML; Pearce CL; Pike MC; Kobel M; Doherty JA; Goode EL; Nelson BH; DeFazio A; Ramus SJ, 2022, 'Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 208, http://dx.doi.org/10.4049/jimmunol.208.Supp.179.04

Meagher NS; deFazio A; Russell K; Voss A; Ramus SJ; Friedlander ML, 2017, 'Mucinous Ovarian Cancers of Uncertain Primary (MO-CUP) - Does the Site of Origin Really Matter?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 73 - 73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Croucher JL; Jonnagaddala J; . Frances M; Caruso L; Meagher NS; Hawkins NJ, 2015, 'In the thick of it: Or how to get tranSMART about data curation', in eResearch Australasia, Brisbane, Australia

Jitendra Jonnagaddala NJH, 2015, 'Integrating biospecimen, clinical, imaging and biomarker data to support translational research: A preliminary study in colorectal cancer', in Biobanking Stakeholder Network Symposium, 22 May 2015, Sydney, Australia

Jonnagaddala J; Croucher JL; Meagher NS; Kumar M; Caruso L; Jue TR; London J; Ward RL; Hawkins NJ, 2015, 'Supporting translational research: Accessing colorectal cancer research data', in Australian Open Research Data Showcase, Canberra, Australia

Meagher NS; Scott G; Hettiaratchi A; Schwensen J; Jonnagaddala J; Caruso L; Ward RL; Crowe P; Salisbury E; Liauw W; others , 2014, 'Two years, fifteen hundred consents and counting. Integrating the HSA Biobank within routine clinical practice within the SESLHD.', in Innovations in Cancer Treatment and Care, Sydney, Australia, 17 October 2014.

Vajdic CM; Chong AH; Kelly PJ; Meagher NS; Van Leeuwen MT; Grulich AE; Webster AC, 2013, 'Survival after cutaneous melanoma in kidney transplant recipients: A population-based matched cohort study', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide Convention Centre, Vol. 9, pp. 134 - 135, presented at Clinical Oncological Society of Australia 40th Annual Scientific Meeting, Adelaide Convention Centre, 12 November 2013 - 14 November 2013, http://dx.doi.org/10.1111/ajco.12145

Vajdic CM; Chong AH; Kelly PJ; Meagher NS; van Leeuwen MT; Grulich AE; Webster AC, 2013, 'Survival after cutaneous melanoma in kidney transplant recipients: A population-based matched cohort study.', in Cancer Research, American Association for Cancer Research, Washington, DC, Vol. 73, presented at 104th Annual Meeting of the American Association for Cancer Research (AACR), Washington, DC, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-2540

Preprints

Heinze K; Nazeran TM; Lee S; Krämer P; Cairns ES; Chiu DS; Leung SCY; Kang EY; Meagher NS; Kennedy CJ; Boros J; Kommoss F; Vollert H-W; Heitze F; du Bois A; Harter P; Grube M; Kraemer B; Staebler A; Kommoss FKF; Heublein S; Sinn H-P; Singh N; Laslavic A; Elishaev E; Olawaiye A; Moysich K; Modugno F; Sharma R; Brand AH; Harnett PR; DeFazio A; Fortner RT; Lubinski J; Lener M; Tołoczko-Grabarek A; Cybulski C; Gronwald H; Gronwald J; Coulson P; El-Bahrawy MA; Jones ME; Schoemaker MJ; Swerdlow AJ; Gorringe KL; Campbell I; Cook L; Gayther SA; Carney ME; Shvetsov YB; Hernandez BY; Wilkens LR; Goodman MT; Mateoiu C; Linder A; Sundfeldt K; Kelemen LE; Gentry-Maharaj A; Widschwendter M; Menon U; Bolton KL; Alsop J; Shah M; Jimenez-Linan M; Pharoah PDP; Brenton JD; Cushing-Haugen KL; Harris HR; Doherty JA; Gilks B; Ghatage P; Huntsman DG; Nelson GS; Tinker AV; Lee C-H; Goode EL; Nelson BH; Ramus SJ; Kommoss S; Talhouk A; Köbel M; Anglesio MS, 2021, Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma, , http://dx.doi.org/10.1101/2021.09.16.21262993

Back to profile page